This prospective study was undertaken to evaluate age distribution of erythrocytes longitudinally throughout pregnancy. Serial estimates of density distribution of cells (DDC), reticulocyte count, red cell distribution width (RDW), and mean corpuscular volume (MCV) in a group of healthy pregnant women at 12, 16, 20, 24, 28, 32 and 36 weeks gestation and during the latent phase of labor (39.04 ± 1.5 weeks). MCV increased constantly during pregnancy; however, the increase was not statistically significant. The mean reticulocyte percentage rose significantly at the 28th week, thereafter it remained at high levels until delivery. RDW increased significantly at the 20th week, remained at high levels until the 32nd week and thereafter declined towards the delivery. The cumulative DDC curve gradually shifted to the right during pregnancy, indicating a less dense cell population as the pregnancy progressed. In conclusion, a continuous alteration in age distribution of erythrocytes towards a younger cell population takes place from early pregnancy until the delivery of the fetus.

Keywords:
Erythrocyte aging, Pregnancy, Hematologic pregnancy complications, Density distribution of cells
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.